DxCodebookFY2027 · Oct 1, 2026 – Sep 30, 2027

Z08 diagnosis code · Billable category · FY2027

Z08 Encounter for follow-up examination after completed treatment for malignant neoplasm

  • Billable
  • Not CC/MCC
  • POA exempt

Z08 ICD-10 code: a billable diagnosis code in FY2027; the category has no subdivisions.

Where it sits

  1. Chapter 21 Factors influencing health status and contact with health services (Z00-Z99)
  2. Z00-Z13 Persons encountering health services for examinations (Z00-Z13)
  3. Z08 Encounter for follow-up examination after completed treatment for malignant neoplasm
CC / MCC
Neither
MS-DRG
826-828, 829-830, 837-839, 846-848
HCC V28
–
POA
Exempt
Code Editor
Unacceptable PDX
Index entries
6

Instructions

At Z08

Inclusion terms

  • Medical surveillance following completed treatment

Excludes1

  • aftercare following medical care (Z43-Z49, Z51) Z43 Z49 Z51

Use additional code

  • code to identify any acquired absence of organs (Z90.-) Z90
  • code to identify the personal history of malignant neoplasm (Z85.-) Z85

Notes that also apply

Block Z00-Z13 instructions (Notes 1, Excludes2 1): printed on the block page.

Chapter 21 instructions (Notes 3): printed on the chapter 21 page.

Index entries

  • Examination (for) (following) (general) (of) (routine)follow-up (routine) (following)malignant neoplasm → Z08
  • Examination (for) (following) (general) (of) (routine)followingtreatment (for)malignant neoplasm → Z08
  • Examination (for) (following) (general) (of) (routine)follow-up (routine) (following)chemotherapy NECmalignant neoplasm → Z08
  • Examination (for) (following) (general) (of) (routine)follow-up (routine) (following)radiotherapy NECmalignant neoplasm → Z08
  • Examination (for) (following) (general) (of) (routine)follow-up (routine) (following)surgery NECmalignant neoplasm → Z08
  • Examination (for) (following) (general) (of) (routine)followingtreatment (for)combined NECmalignant neoplasm → Z08

NCHS Alphabetic Index. Index first, then the Tabular List.

Medicare grouping and edits

CMS files for Z08
CC / MCCNeither
Appendix BMDC 17 Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms, MS-DRG 826-828 (Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with MCC…); MDC 17 Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms, MS-DRG 829-830 (Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures with CC/MCC…); MDC 17 Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms, MS-DRG 837-839 (Chemotherapy with Acute Leukemia as Secondary Diagnosis or with High Dose Chemotherapy Agent with MCC…); MDC 17 Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms, MS-DRG 846-848 (Chemotherapy without Acute Leukemia as Secondary Diagnosis with MCC…)
Code EditorUnacceptable principal diagnosis
POAExempt
HCC V28–

CMS: MS-DRG v44 (Appendix B, C), MCE v44, POA list FY2027, 2027 Initial ICD-10-CM Mappings. What the rows mean.

Hierarchy